Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazoxide at Bedtime in Newly Diagnosed Type 1 Diabetes
NCT00131755Phase 4Completed
- Start
- Feb 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Diazoxide with Placebo (2 arms). Primary endpoints: Insulin secretion at 12 months and Glycemic control at 12 months. Started Feb 2005; status: completed.
02
Drugs
diazoxide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00131755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131755.